Remicade has been studied in several clinical trials for the following conditions:
Remicade for Ankylosing Spondylitis
Clinical studies have shown that Remicade is effective at improving the symptoms of ankylosing spondylitis. People taking the drug showed greater improvements in their symptoms when compared to those not taking it.
Remicade for Crohn's Disease
Remicade was also studied for
Crohn's disease treatment. In one study, up to 81 percent of those taking the drug showed improvement in
Crohn's disease symptoms, compared to just 16 percent of those not taking it. The drug also increased the chance of remission, and people taking it were more likely to stop taking steroids for Crohn's disease.
Remicade was also shown to decrease the number of fistulas in people with Crohn's disease. Other studies have shown that the drug is safe and effective for treating Crohn's disease in children as young as six years old.
Remicade for Plaque Psoriasis
In clinical studies, Remicade has been shown to improve the symptoms of plaque psoriasis. In one study, up to 88 percent of those taking it showed a large improvement in their psoriasis symptoms, compared to just 6 percent of those not taking the drug.
Psoriatic Arthritis
In a study of Remicade for psoriatic
arthritis, the drug was shown to reduce pain and other symptoms, including joint stiffness. In addition, the drug helped to lessen the physical joint changes associated with psoriatic arthritis when compared to those not taking it.
Previous
Add this article to your Favorites
Email this article
Print